trademark-notice 
Canna Law Blog
FEBRUARY 19, 2022
While cannabis brands need to be mindful of cannabis-specific trademark issues, they must also pay attention to trademarking basics. Back in January, we discussed three key trademark issues: distinctiveness, likelihood of confusion, and application bases. However, during that time their trademark remains unregistered.
Canna Law Blog
JANUARY 10, 2022
The registration of cannabis trademarks in the United States raises novel issues. At the same time, however, they should not neglect the trademark basics. At the same time, however, they should not neglect the trademark basics. Cannabis trademarks must be distinctive. Use in Commerce.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
MAY 11, 2019
We’ve referenced the Trademark Trial and Appeals Board (TTAB) in numerous posts related to protecting your cannabis trademarks, but many clients come to me unaware of the functions of the TTAB. This post will give a basic rundown of what the TTAB does, and what the trademark opposition process looks like.
Canna Law Blog
APRIL 10, 2020
On March 16, the United States Patent and Trademark Office (USPTO) issued a statement regarding Relief Available to Patent and Trademark Applicants, Patentees and Trademark Owners Affected by the Coronavirus Outbreak. No failure or delay in performance under this Agreement due to a force majeure event (i.e.,
Canna Law Blog
JANUARY 12, 2019
We hear from clients on a regular basis who receive fraudulent notices pertaining to their U.S. federal trademark applications, and because we’ve seen an uptick in these scams over the last month, we thought it would be prudent to publish a PSA on the topic, together with what to look out for if you are a trademark applicant or owner.
Cannabis Law Report
APRIL 28, 2022
Why have high profile brands flocked to register trademarks for their digital wares? Big brands have quickly taken notice of this new landscape. Well, the metaverse just might be able to assist cannabis brands in developing and protecting nationwide trademark rights. So, what exactly is the metaverse?
Cannabis Law Report
AUGUST 22, 2021
Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Patent Office issued a notice of allowance for its technology/method patent covering an isolated homing peptide and how it can help deliver drugs to the central nervous system (CNS). Silo Pharma Inc.
Expert insights. Personalized for you.
80 
Let's personalize your content